Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
151-165 of 474
Blood-Based Colorectal Cancer Screening: Where Do We Stand?
Clinician's RoundtableBlood-Based Colorectal Cancer Screening: Where Do We Stand?
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Optimizing Multidisciplinary Care in Perioperative NSCLC
Project Oncology®Optimizing Multidisciplinary Care in Perioperative NSCLC
Steve Jackson, PharmD
David Tom Cooke, MD, FACS
Joshua Reuss, MD
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Neil M. Iyengar, MD
Sarah H. Donahue, MPH, NP
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Project Oncology®Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Brian P. McDonough, MD, FAAFP
Bilal Siddiqui, MD
Improving CRC Screening Workflows: A PCP's Recommendations
Clinician's RoundtableImproving CRC Screening Workflows: A PCP's Recommendations
Natalia Usoltseva MD, FACP, MHA
Improving CRC Screening Conversations in Primary Care
Clinician's RoundtableImproving CRC Screening Conversations in Primary Care
Natalia Usoltseva MD, FACP, MHA
- advertisement
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Project Oncology®Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Charles Turck, PharmD, BCPS, BCCCP
Petros Grivas, MD, PhD
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Project Oncology®Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Raghava Reddy Induru, MD
Making Mechanism-Based Treatment Decisions in cGVHD
Project Oncology®Making Mechanism-Based Treatment Decisions in cGVHD
Brian P. McDonough, MD, FAAFP
Alicia Lieberman, MD, MS
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Project Oncology®Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Raghava Reddy Induru, MD
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Brian P. McDonough, MD, FAAFP
Madison Conces, MD
Midhun Malla, MD
Preventing Colorectal Cancer with Smart Screening
Clinician's RoundtablePreventing Colorectal Cancer with Smart Screening
Harish Gagneja, MD
- advertisement
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Clinician's RoundtableOptimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Pedro Nascimento de Lima, PhD
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Clinician's RoundtableBlood-Based Screening for Colorectal Cancer: Benefits and Limitations
Aasma Shaukat, MD, MPH
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's RoundtableWeighing the Environmental Impact of Colorectal Cancer Screening Methods
Peter Buch, MD, FACG, AGAF, FACP
A. Mark Fendrick, MD